Certified by Founder Lodge
F-Prime Capital
United States - Cambridge, MA
INVESTOR
1 Disclosed Funding Rounds $112,000,000
235 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management f
| Company | Date | Round | Raised |
|---|---|---|---|
Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Burro |
January, 10 ,2024 | Series B | $24,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
R1 Therapeutics |
March, 18 ,2026 | Series A | $77,500,000 |
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Almanac Health |
April, 24 ,2026 | Seed | $10,000,000 |
Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
R1 Therapeutics |
March, 18 ,2026 | Series A | $77,500,000 |
Almanac Health |
April, 24 ,2026 | Seed | $10,000,000 |
Expressable
Ensoma
Albert Invent
Rippl
Bicara Therapeutics
RightHand Robotics, Inc
Paradigm
Mathison
Teleo
Burro
Adela, Inc.
Engrail Therapeutics
R1 Therapeutics
Almanac Health
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Kibu, Inc | $10,500,000 | (May 5, 2026)
Fun | $72,000,000 | (May 5, 2026)
LakeFusion | $7,500,000 | (May 5, 2026)
Featherless AI | $20,000,000 | (May 5, 2026)
Zapdos Labs | $500,000 | (May 5, 2026)